A Lasting Impact: COVID-19 and Cancer Screening
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers
Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities
Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.